12:10 PM
 | 
Oct 06, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Visterra tops off series C round

On Oct. 5, anti-infectives company Visterra Inc. (Cambridge, Mass.) raised $23.6 million in an extension of a series C round, bringing the round's total to $46.7 million. Visterra raised an initial $23.1 million close in June...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >